文献速递免疫规划

HIV1 gp120片段免疫原在病毒样颗粒上的设计、展示与免疫原性

Design, display and immunogenicity of HIV1 gp120 fragment immunogens on virus-like particles.
PubMed 文献 · Vaccine · 2018-09-14

研究将HIV-1 gp120外结构域片段b122a及其稳定化突变体展示于Qβ病毒样颗粒,并在兔中进行了为期六个月的免疫研究。突变体b122a1-b稳定性提高,与b12抗体亲和力较b122a提高30倍;展示b122a1-b的颗粒诱导的血清可中和不同亚型Tier1病毒,并显著诱导更多针对CD4bs的抗体。

要点

  • b122a1-b突变体稳定性提高,与b12亲和力较b122a提高30倍。
  • 展示b122a1-b的Qβ颗粒诱导血清中和不同亚型Tier1病毒效果最佳。
  • 展示b122a1-b的颗粒诱导显著更高水平的CD4bs定向抗体。

核心结论

  • 片段免疫原能够将抗体反应聚焦于HIV-1保守的CD4bs。

研究设计与样本

  • 设计E. coli表达的HIV-1 gp120片段b122a(含约70%的b12表位),并通过引入额外二硫键获得稳定化突变体b122a1-b。
  • 将多种b122a和OD片段蛋白展示于Qβ病毒样颗粒表面,并在兔中进行为期六个月的免疫研究。

主要发现

  • b122a1-b稳定性提高,与b12的亲和力较b122a提高30倍。
  • 展示b122a1-b的颗粒诱导的血清可中和不同亚型的Tier1病毒,为最佳结果。
  • 展示b122a1-b的颗粒诱导的针对CD4bs的抗体量显著更高。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The broadly neutralizing antibody against HIV-1, b12, binds to the CD4 binding site (CD4bs) on the outer domain (OD) of the gp120 subunit of HIV-1 Env. We have previously reported the design of an E. coli expressed fragment of HIV-1 gp120, b122a, containing about 70% of the b12 epitope with the idea of focusing the immune response to this structure. Since the b122a structure was found to be only partially folded, as assessed by circular dichroism and protease resistance, we attempted to stabilize it by the introduction of additional disulfide bonds. One such mutant, b122a1-b showed increased stability and bound b12 with 30-fold greater affinity as compared to b122a. Various b122a and OD fragment proteins were displayed on the surface of Qβ virus-like particles. Sera raised against these particles in six-month long rabbit immunization studies could neutralize Tier1 viruses across different subtypes with the best results observed with b122a1-b displayed particles. Significantly higher amounts of antibodies directed towards the CD4bs were also elicited by particles displaying b122a1-b. This study highlights the ability of fragment immunogens to focus the antibody response to the conserved CD4bs of HIV-1.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Purwar M, Pokorski JK, Singh P, et al. Design, display and immunogenicity of HIV1 gp120 fragment immunogens on virus-like particles. Vaccine. 2018. PMID: 30220462. doi:10.1016/j.vaccine.2018.07.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。